Procter & Gamble (NYSE:PG) Trading 1.1% Higher - Here's Why

Key Points

• Procter & Gamble beat quarterly EPS expectations with $1.59 vs. $1.56 and set FY2026 guidance of EPS 6.83–7.09, while revenue of $21.24 billion slightly missed estimates, indicating earnings resilience but mixed top-line momentum.
• The company raised its quarterly dividend to $1.0885 (annualized $4.35, ~3.0% yield), and the stock traded up about 1.1% to roughly $145 on the day.
• Analysts have trimmed target prices and some ratings amid concerns about weak consumer volumes that could limit growth, and significant insider selling contrasts with continued heavy institutional ownership.

Procter & Gamble Company (The) (NYSE:PG - Get Free Report)'s stock price traded up 1.1% during trading on Tuesday . The company traded as high as $145.90 and last traded at $144.9660. 7,348,882 shares changed hands during trading, a decline of 32% from the average session volume of 10,818,635 shares. The stock had previously closed at $143.42.

Procter & Gamble News Summary

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Reported earnings slightly above expectations and set FY2026 guidance (management sees EPS 6.83–7.09), supporting confidence in profit trajectory despite mixed top-line signals.
• Positive Sentiment: Olay launched a major “Skinsurance” campaign around its clinically backed Super Collection, a brand push intended to drive skincare premiumization and long-term category growth. Olay Skinsurance press release
• Neutral Sentiment: Analyst target-price coverage is being refreshed across outlets, keeping PG front of mind for income and defensive-growth investors but producing no clear consensus catalyst. Analyst target-price roundup
• Neutral Sentiment: Pantene introduced a seasonal leave-in protection spray and Metamucil launched a digital content series—marketing initiatives that can modestly support category share and e-commerce engagement but are unlikely to move near-term results materially. Pantene launch Metamucil campaign
• Neutral Sentiment: Coverage noting PG in valuation/portfolio screens (e.g., “Dogs of the Dow” commentary and valuation rechecks) highlights investor interest in PG’s income and defensive attributes but does not imply immediate directional pressure. Dogs of the Dow article Valuation recheck
• Negative Sentiment: Analyses flag weak consumer volumes in several categories; while management is offsetting cost pressure with productivity and supply-chain moves, sustained volume weakness could limit top-line growth and cap multiple expansion. Cost-discipline vs. weak volumes analysis

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Erste Group Bank lowered shares of Procter & Gamble from a "buy" rating to a "hold" rating in a report on Tuesday, March 24th. Barclays decreased their target price on shares of Procter & Gamble from $155.00 to $146.00 and set an "equal weight" rating for the company in a research report on Tuesday, April 14th. Bank of America decreased their target price on shares of Procter & Gamble from $171.00 to $167.00 and set a "buy" rating for the company in a research report on Friday, April 10th. The Goldman Sachs Group decreased their target price on shares of Procter & Gamble from $159.00 to $155.00 and set a "neutral" rating for the company in a research report on Wednesday, April 8th. Finally, Royal Bank Of Canada decreased their target price on shares of Procter & Gamble from $172.00 to $167.00 and set an "outperform" rating for the company in a research report on Thursday, April 9th. Eleven investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $161.06.

Procter & Gamble Trading Up 1.1%

The business's 50-day moving average price is $149.44 and its 200 day moving average price is $148.62. The company has a market cap of $337.57 billion, a P/E ratio of 21.19, a P/E/G ratio of 6.31 and a beta of 0.41. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.53 and a current ratio of 0.73.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Friday, April 24th. The company reported $1.59 EPS for the quarter, beating analysts' consensus estimates of $1.56 by $0.03. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The company had revenue of $21.24 billion during the quarter, compared to the consensus estimate of $21.52 billion. During the same quarter last year, the firm posted $1.54 EPS. The company's quarterly revenue was up 7.4% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, analysts expect that Procter & Gamble Company will post 6.92 earnings per share for the current year.

Procter & Gamble Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 24th will be given a $1.0885 dividend. This is a boost from Procter & Gamble's previous quarterly dividend of $1.06. The ex-dividend date of this dividend is Friday, April 24th. This represents a $4.35 dividend on an annualized basis and a dividend yield of 3.0%. Procter & Gamble's payout ratio is 63.60%.

Insider Buying and Selling

In other news, insider Moses Victor Javier Aguilar sold 15,169 shares of Procter & Gamble stock in a transaction dated Friday, February 13th. The shares were sold at an average price of $162.28, for a total value of $2,461,625.32. Following the completion of the transaction, the insider owned 44,735 shares of the company's stock, valued at $7,259,595.80. This trade represents a 25.32% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Balaji Purushothaman sold 12,827 shares of the firm's stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $160.31, for a total transaction of $2,056,296.37. Following the sale, the insider owned 12,639 shares of the company's stock, valued at approximately $2,026,158.09. This represents a 50.37% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 252,715 shares of company stock worth $40,966,904. Corporate insiders own 0.20% of the company's stock.

Institutional Trading of Procter & Gamble

A number of hedge funds have recently modified their holdings of PG. Norges Bank acquired a new stake in shares of Procter & Gamble during the 4th quarter worth about $4,664,783,000. Cardano Risk Management B.V. lifted its stake in shares of Procter & Gamble by 1,104.8% during the 4th quarter. Cardano Risk Management B.V. now owns 9,521,440 shares of the company's stock worth $1,364,518,000 after buying an additional 8,731,126 shares during the last quarter. Auto Owners Insurance Co lifted its stake in shares of Procter & Gamble by 14,231.0% during the 4th quarter. Auto Owners Insurance Co now owns 3,549,645 shares of the company's stock worth $508,700,000 after buying an additional 3,524,876 shares during the last quarter. Vanguard Group Inc. raised its stake in Procter & Gamble by 1.2% in the 4th quarter. Vanguard Group Inc. now owns 237,459,756 shares of the company's stock worth $34,030,358,000 after purchasing an additional 2,829,151 shares in the last quarter. Finally, Assenagon Asset Management S.A. raised its stake in Procter & Gamble by 100.8% in the 4th quarter. Assenagon Asset Management S.A. now owns 5,460,939 shares of the company's stock worth $782,607,000 after purchasing an additional 2,741,924 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.

Procter & Gamble Company Profile

Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.